Development of a pharmacodynamic biomarker of opioid antagonism in adolescents with eating disorders: Study protocol for the naltrexone neuroimaging randomized controlled trial (NN-RCT)Stephani L. Stancil, Laura E. Martin, Anna Burns et al.|Contemporary Clinical Trials|2025Cited by 1
Development of a Pharmacodynamic Biomarker of Opioid Antagonism in Adolescents with Eating Disorders: Study Protocol for the Naltrexone Neuroimaging Randomized Controlled Trial (Nn-Rct)Stephani L. Stancil, Laura E. Martin, Mariah Brewe et al.|SSRN Electronic Journal|2024Cited by 0